Waters Corporation (WAT) stock increased by 0.96% due to positive adjustments in holdings by major investors and favorable quarterly earnings that exceeded analysts' expectations, driving investor confidence.

Waters Corporation (WAT) stock increased by 0

Waters Corporation's stock (WAT) declined 3.16% after Wells Fargo downgraded its rating from strong-buy to hold and lowered the target price from $420 to $330, indicating decreased investor confidence in the company’s prospects.

Waters Corporation's stock (WAT) declined 3

Waters Corporation (WAT) stock rose by 2.54% last night, likely driven by increased institutional investment, positive quarterly earnings that exceeded estimates, and favorable ratings from various analysts indicating a "Moderate Buy" consensus.

Waters Corporation (WAT) stock rose by 2

Waters Corporation (WAT) stock rose by 2.54% following significant new acquisitions by institutional investors, indicating growing confidence in the company, particularly after it reported better-than-expected earnings and revenue growth.

Waters Corporation (WAT) stock increased by 2.54% following the announcement of its merger with BD and Company's Biosciences and Diagnostic Solutions, which is expected to significantly benefit existing shareholders who will own a substantial portion of the combined entity.

Waters Corporation (WAT) stock increased by 2

Waters Corporation (WAT) stock remained unchanged at 0.0% down amid ongoing investigations by Halper Sadeh LLC into potential violations of federal securities laws related to its merger with BD, which may raise concerns among investors about the implications of the transaction.

Waters Corporation (WAT) stock remained unchanged at 0

Waters Corporation (WAT) stock declined by $42.73 to $310.18 amid active trading, alongside other pharmaceutical stocks, although specific reasons for the drop were not detailed. 

The decline in WAT stock could be attributed to broader market dynamics affecting pharmaceutical stocks, which are influenced by factors such as trading volumes, market sentiment, and competitive pressures in the sector.

Waters Corporation (WAT) stock declined by $42

Waters Corporation (WAT) stock fell 13.81% due to concerns over a potential merger with Becton, Dickinson and Company, including allegations that the Waters Board may have breached its fiduciary duties by not conducting a fair process, which could dilute shareholder value in the combined entity.

Waters Corporation (WAT) stock fell 13

Waters Corporation (WAT) stock dropped by 13.81% likely due to legal investigations related to its proposed merger with BD and Company’s Biosciences & Diagnostic Solutions business, prompting concerns among investors regarding potential violations of federal securities laws and breaches of fiduciary duties.

Waters Corporation (WAT) stock dropped by 13

Waters Corporation (WAT) stock rose 0.41% following an upgrade in ratings from several research firms, leading to a consensus rating of "Moderate Buy" and favorable earnings results that exceeded analyst expectations.

Waters Corporation (WAT) stock rose 0

Waters Corporation (WAT) stock declined by 0.48% as various hedge funds reported an increase in their holdings, showing mixed investor sentiment, while the stock is still supported by a generally favorable rating from analysts. The decline may reflect broader market trends or profit-taking, rather than any specific negative news about the company itself.

Waters Corporation (WAT) stock declined by 0

Waters Corporation (WAT) stock rose 2.29% due to increased institutional investments, including significant stake increases by GAMMA Investing LLC and other hedge funds, indicating strong investor confidence in the company.

Waters Corporation (WAT) stock rose 2

Last night, Waters Corporation (WAT) stock decreased by 0.7%, potentially influenced by mixed analyst ratings and some adjustments in institutional holdings without significant new positive news about the company.

Last night, Waters Corporation (WAT) stock decreased by 0

Waters Corporation (WAT) saw a 1.16% increase in its stock value, driven by significant investment from institutional investors, who have recently increased their positions in the company, indicating strong market confidence and positive earnings performance that exceeded analysts' expectations.

Waters Corporation (WAT) saw a 1

Waters Corporation's stock (NYSE: WAT) rose by 0.06% due to increased institutional investment in the company, indicated by significant upticks in holdings from several funds, along with strong earnings performance that exceeded analysts' expectations.

Waters Corporation's stock (NYSE: WAT) rose by 0

Waters Corporation's (WAT) stock rose by 0.06% due to its involvement in the rapidly expanding graphitized carbon black (GCB) market, which is experiencing robust growth driven by increasing demand for conductive materials in electric vehicles and advancements in laboratory technologies, particularly related to environmental contaminant testing.

Waters Corporation's (WAT) stock rose by 0

Waters Corporation (WAT) stock experienced a decline of 1.93% following a reduction in holdings by institutional investors and a downgrade from "buy" to "hold" by Wall Street analysts, indicating shifting investor sentiment and potential concerns about the company's performance.

Waters Corporation (WAT) stock experienced a decline of 1

Waters Corporation (NYSE:WAT) experienced a decline of -1.08% in its stock value, despite analysts generally recommending it as a "Moderate Buy" and recent positive quarterly earnings, likely due to mixed ratings from investment firms and changes in target prices that may have influenced investor sentiment.

Waters Corporation (NYSE:WAT) experienced a decline of -1

Waters Corporation (WAT) stock increased by 0.43%, driven by investment activity from institutional investors and positive analyst ratings, including raised target prices from firms like JPMorgan and Wells Fargo, after the company reported better-than-expected quarterly earnings and revenue.

Waters Corporation's stock (WAT) fell by 0.81%, influenced by mixed responses from institutional investors and changes in analyst target prices despite the company reporting positive quarterly earnings. The decline may reflect investor sentiment regarding future valuation adjustments, as prominent firms updated their price targets lower, such as Bank of America decreasing theirs from $430.00 to $410.00.

WAT

Latest News & Analysis